We recently reported that pharmacological inhibition of HSP90 by PU-H71 was not only associated with augmented cell death and decreased cancer cell proliferation but also lead to destabilization and subsequent proteasomal degradation of protein kinase D2 (PKD2)10. Here, HSP90AB1 is linked to cancer.